ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO636

Fluorescent Reporters in Kidney Organoids Generated with Cheap Mini-Bioreactors for High-Throughput Modeling of Kidney Fibrosis

Session Information

Category: Development, Stem Cells, and Regenerative Medicine

  • 501 Development, Stem Cells, and Regenerative Medicine: Basic

Authors

  • Sun, Zhao, Renal Division Washington University School of Medicine, Saint Louis, Missouri, United States
  • Uchimura, Kohei, Renal Division Washington University School of Medicine, Saint Louis, Missouri, United States
  • Wu, Haojia, Renal Division Washington University School of Medicine, Saint Louis, Missouri, United States
  • Donnelly, Erinn L., Renal Division Washington University School of Medicine, Saint Louis, Missouri, United States
  • Humphreys, Benjamin D., Renal Division Washington University School of Medicine, Saint Louis, Missouri, United States
Background

Kidney organoids from human pluripotent stem cells (hPSCs) provide a unique opportunity to study human kidney development and kidney diseases. Current protocols are low throughput, generate immature and off-target cell types, and are costly. We tested the ability of spinning bioreactors to overcome these limitations.

Methods

We 3D-printed spinning mini-bioreactors that fit onto 12-well plates, as described (Qian et.al. Cell, 2016). We adapted the Takasato organoid differentiation protocol to the spinning mini-bioreactors by initially differentiating hPSC in a mono-layer for 7 days, followed by low-attachment plate culturing to generate spheroids for another 5 days, and then transferring the spheroids to a mini-bioreactor for maturation for 7- 42 days. We optimized the throughput and characterized resulting kidney organoids by qPCR, immunofluorescence and single cell RNA-seq (scRNA-seq). Finally, we generated and validated three novel fluorescent reporter hPSC lines relevant to the study of fibrosis in kidney organoids (Fibronectin1-GFP, Col1a1-GFP and Gli1-turboGFP).

Results

One 12-well plate could generate 200-600 kidney organoids, representing a more than 100 – fold increase compared to the original Takasato protocol. scRNA-seq analysis revealed that when compared to the standard organoid protocol using a transwell plate, the kidney organoids generated with the mini-bioreactor exhibit more mature nephron structures (including ureteric bud), and more closely resemble the adult human kidney by Pearson correlation. We validated that Fibronectin1-GFP, CollA1-GFP and Gli1-turboGFP all express in the correct stromal cell type in mini-bioreactor-derived organoids. Furthermore, kidney organoids generated by the mini-bioreactor method mount a fibrotic response when treated with 20 µM cisplatin for 2 days by using RPMI medium for organoid differentiation.

Conclusion

We used a 3D-printed spinning mini-bioreactor to increase kidney organoid throughput by at least 100-fold. The protocol is cheaper and results in better differentiation of nephron structures when compared to the standard protocol using a transwell plate. We have generated and validated novel fluorescent reporter hPSC lines relevant to studying fibrosis. This work will accelerate adoption of kidney organoid protocols for the research community.

Funding

  • NIDDK Support